An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
2015 · Scientific Reports · 14 citations
https://doi.org/10.1038/srep17105
V
Vidyullatha Vasireddy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.2K
Citations
17
h-index
18
i10-index
Vidyullatha Vasireddy is an academic researcher from Io Therapeutics (United States). The author has contributed to research in topics: Retinal Development and Disorders & Retinal Diseases and Treatments & Virus-based gene therapy research. The author has an h-index of 17, co-authored 37 publications.
Papers by this author
worksAn in vitro and in vivo efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPs
2024 · Molecular Therapy — Methods & Clinical Development · 4 citations
https://doi.org/10.1016/j.omtm.2024.101354
Author Correction: An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
2018 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-018-35960-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat